Advertisement
Home »

AHA and ACC Issue 2024 Clinical HCM Management Guidelines

Aug 22, 2024

REFERENCES & ADDITIONAL READING

Ommen S, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. JACC. 2024 Jun, 83 (23) 2324–2405. doi:10.1016/j.jacc.2024.02.014

Ommen S, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239-e1311. doi:10.1161/CIR.0000000000001250

ABOUT THE EXPERTS

  • Professor of Medicine
    Consultant, Division of Structural Heart Disease
    Chair for Clinical Practice, Division of Structural Heart Disease
    Director, Hypertrophic Cardiomyopathy Clinic
    Department of Cardiovascular Medicine
    Mayo Clinic

     

    Steve R. Ommen, MD, has indicated to Physician’s Weekly that he has no financial interests to disclose.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement